Filling biologics in prefilled syringes is governed by three degradation pathways that the equipment directly influences: oxidation from headspace oxygen, aggregation induced by silicone oil, and aggregation induced by tungsten residues and shear. Because the number of oxygen molecules sealed into the syringe scales with the absolute pressure at the moment of stoppering, vacuum stoppering is the single most direct equipment control over headspace oxygen — and therefore over oxidative shelf life.
This article is written for biologics manufacturing, formulation and stability teams, and for the CDMOs filling on their behalf. It focuses on what the filling equipment can and cannot control. Container and formulation choices matter at least as much, but they are decided elsewhere; here we deal with the machine.
The headspace oxygen budget: do the arithmetic once
Most stability discussions treat headspace oxygen qualitatively — “we want it low.” It is more useful to count the molecules. The calculation is elementary and the result is usually a surprise.
How much oxygen is in an air headspace?
Ideal gas at 25 °C and 1 atm · molar volume 24.45 L/mol · air is 20.9% O₂
Illustrative, using stated assumptions. Not all of that oxygen reacts, and reaction rate depends on formulation, excipients and storage. The point is that an air headspace is not an oxygen-limited environment — the reservoir comfortably exceeds the susceptible residues (methionine, tryptophan, cysteine, histidine) available to oxidise.
Why vacuum stoppering changes this number
At constant headspace volume and temperature, the moles of gas trapped scale linearly with the absolute pressure at the instant the stopper seals. Stopper the syringe at atmospheric pressure and you seal in a full air charge. Stopper it under vacuum and you seal in proportionally less.
| Absolute pressure at stoppering | O₂ sealed in (0.5 mL headspace) | Molar ratio to mAb | Assessment |
|---|---|---|---|
| 100% (atmospheric) | 4.27 µmol | 6.4 : 1 | Large oxygen reservoir |
| 50% | 2.14 µmol | 3.2 : 1 | Halved |
| 20% | 0.85 µmol | 1.3 : 1 | Approaching stoichiometric |
| 10% | 0.43 µmol | 0.6 : 1 | Oxygen becomes limiting |
An important caveat. The table above is physics, not a machine specification. We do not publish a guaranteed residual headspace oxygen percentage for our equipment, because the achieved value depends on your vacuum setpoint, dwell time, stopper geometry, gel or liquid properties and line configuration. Measure it on your own line — by headspace gas analysis on filled units — and qualify the vacuum level and dwell time as process parameters during OQ. Treat any supplier who quotes you a guaranteed headspace oxygen figure without running your product as making a claim they cannot support.
Three degradation pathways the filling line touches
Oxidation is the pathway most people name. It is not the only one, and on prefilled syringes it is arguably not the most troublesome.
| Pathway | Mechanism | Equipment / component lever |
|---|---|---|
| Oxidation | Headspace and dissolved O₂ oxidise susceptible residues — methionine, tryptophan, cysteine, histidine — altering potency and immunogenicity risk. | Vacuum stoppering; optional inert gas overlay; minimising headspace volume |
| Silicone-oil-induced aggregation | Silicone oil lubricating the barrel migrates into the product and forms an oil–water interface at which proteins adsorb, unfold and aggregate into sub-visible particles. | Container choice (baked-on vs sprayed silicone, or silicone-free); avoid unnecessary agitation on the line |
| Tungsten- and shear-induced aggregation | Residual tungsten from the pin used to form the glass syringe cone can nucleate aggregation. Shear and air–liquid interfacial stress during filling contribute independently. | Low-tungsten syringes; slow, servo-controlled fill profile; needle geometry; bottom-up filling |
Note carefully that two of the three levers sit with your container supplier, not your machine supplier. An equipment vendor who tells you the machine alone solves biologics stability is overselling. What the machine genuinely controls is headspace oxygen, fill-induced shear, and whether air is entrained at the meniscus.
Key Takeaways for Stability & Engineering
- A 0.5 mL air headspace supplies roughly 6.4 O₂ molecules per antibody molecule — the reservoir is not oxygen-limited.
- Moles of trapped gas scale with the absolute pressure at stoppering. Vacuum stoppering is the direct lever.
- Do not accept a guaranteed headspace O₂ figure from any supplier who has not run your product. Measure it; qualify vacuum level and dwell at OQ.
- Silicone oil and tungsten residues drive aggregation and are container issues, not machine issues. Two of three levers are not the filler’s.
- Fill slowly, bottom-up, with a servo-controlled profile. Shear and air–liquid interface are aggregation drivers.
- Demand sub-visible particle testing on your own protein at FAT — not a water run.
What the equipment must do
Vacuum fill and vacuum stopper
Evacuate the barrel during the fill so no air is entrained at the meniscus, then seat the stopper under vacuum to minimise the sealed gas charge.
Slow, servo-controlled fill profile
Fill speed and acceleration are qualifiable process parameters. Excess velocity generates shear and interfacial stress that nucleate aggregates.
Bottom-up needle retraction
The needle starts at the base of the barrel and rises with the liquid level, eliminating jetting, splashing and air–liquid interface renewal.
Optional inert gas overlay
Where residual oxygen must go lower than vacuum stoppering alone achieves, a nitrogen or argon purge can be combined with the vacuum cycle.
Short, low-hold-up product path
AISI 316L contact parts, no sanitary dead corners, minimal residence time. Biologic bulk is expensive and prolonged residence encourages adsorption.
Precise, repeatable stoppering depth
Stoppering depth sets both the headspace volume and the container closure geometry. It must be reproducible, not “approximately right.”
Filling a monoclonal antibody or other oxygen-sensitive biologic? Send us the formulation and syringe format — we’ll discuss vacuum setpoints and what to measure, before you buy anything.
Request a Formulation Review
Forester Xiang
Founder & Chief Engineer
20+ years in sterile filling
I will say something about our own machine that most vendors would rather you didn’t hear. A ceramic plunger pump imposes shear on your protein. It is a positive-displacement device with a tight clearance, and shear-sensitive molecules feel it. The accuracy is excellent — that’s why we use it — but the pump is not innocent.
What you do about that is qualify the fill profile. Run your protein, slowly, and count the sub-visible particles before and after the pump. If the particle count is acceptable, you have your answer, documented. If it isn’t, we change the speed, the needle, or the fill volume per stroke until it is. What you must never do is accept a water run and hope. Water has no methionine to oxidise and no tertiary structure to unfold.
What to demand at Factory Acceptance Testing
The FAT is where these arguments get settled with data rather than opinion. Insist on the following, written into the protocol before the test date.
Biologics FAT checklist
The supplier’s obligations around FAT protocols, IQ/OQ templates and material certificates are set out in our guide to cGMP and IQ/OQ/PQ for an aseptic syringe filling line. If your product is viscous as well as oxygen-sensitive, the reasoning in vacuum versus standard filling applies with double force. Both the HIJ-GZB-100 and its double-head counterpart perform vacuum filling and vacuum stoppering with AISI 316L product-contact parts and a cGMP-ready design.
Frequently asked questions
How much oxygen is in the headspace of a prefilled syringe?
Does vacuum stoppering reduce headspace oxygen?
Why does silicone oil cause protein aggregation in prefilled syringes?
What is the tungsten problem in glass prefilled syringes?
Does the filling pump damage the protein?
Should we use an inert gas overlay as well as vacuum stoppering?
Filling Biologics in Prefilled Syringes — Reference Facts
Qualify the Fill Profile on Your Protein
Send us your formulation, syringe format and stability concerns. We’ll define the FAT protocol together — headspace gas analysis, particle counts, bracketed fill speeds — and quote transparently.
Get Free Turnkey Quote
